Stratifying and tailoring HbA1c control targets for adults with Type 2 diabetes: Interpretation of the consensus proposed by the Chinese Society of Endocrinology

Journal of Diabetes

Volumn 3, Issue 3, 2011, Pages 201-207

  Cao, Ming Ming ^a   Tong, Nan Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Consensus; Glycemic control; HbA1c; Hypoglycemia; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES CONTROL; DIET THERAPY; ELDERLY CARE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; CONSENSUS; DIABETES MELLITUS, TYPE 2; ENDOCRINOLOGY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 80051827454     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00133.x     Document Type: Review

References (34)

1. Steffes M, Molitch M, Chavers B et al. Sustained effect of intensive treatment of Type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Am Med Assoc. 2003; 290: 2159-67.
2. Shichiri M, Kishikawa H, Ohkubo Y et al. Long-term results of the Kumamoto Study on optimal diabetes control in Type 2 diabetic patients. Diabetes Care. 2000; 2: 21-9.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53.
4. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med. 2005; 353: 2643-53.
5. Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med. 2008; 359: 1618-20.
6. ACCORD Study Group. Effects of intensive blood-pressure control in Type 2 diabetes mellitus. N Engl J Med. 2010; 362: 1575-85.
7. Reaven PD, Moritz TE, Schwenke DC et al. Intensive glucose-lowering therapy reduces cardiovascular disease events in Veterans Affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes. 2009; 58: 2642-8.
8. Skyler JS, Bergenstal R, Bonow RO et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009; 32: 187-92.
9. American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care. 2010; 33 (Suppl. 1): S11-61.
10. International Diabetes Federation. World Diabetes Conference Montreal. Available from: (accessed 21 February 2011).
11. Rodbard HW, Jellinger PS, Davidson JA et al. AACE/ACE Consensus Statement. Endocr Pract. 2009; 15: 540-59.
12. Home P, Mant J, Diaz J, Turner C, Guideline Development Group. Management of Type 2 diabetes: Summary of updated NICE guidance. Br Med J. 2008; 336: 1306-8.
13. Del Prato S, LaSalle J, Matthaei S, Bailey CJ, Global Partnership for Effective Diabetes Management. Tailoring treatment to the individual in Type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int J Clin Pract. 2010; 64: 295-304.
14. Woo V. Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009; 52: 552-3.
15. Chinese Diabetes Society. China guideline for Type 2 diabetes (2007). Available from: (accessed 1 March 2011).
16. Del Prato S. Megatrials in Type 2 diabetes. From excitement to frustration? Diabetologia. 2009; 52: 1219-26.
17. Selvin E, Marinopoulos S, Berkenblit G et al. Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Am Coll Physicians. 2004; 141: 421-31.
18. Ganda OP, Center JD. A targeted, multifactorial intervention reduced mortality in patients with Type 2 diabetes and microalbuminuria. N Engl J Med. 2008; 358: 580-91.
19. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with Type 2 diabetes mellitus. Arch Intern Med. 2001; 161: 1653-9.
20. Espeland M. Reduction in weight and cardiovascular disease risk factors in individuals with Type 2 diabetes: One-year results of the Look AHEAD trial. Diabetes Care. 2007; 30: 1374-83.
21. Currie CJ, Peters JR, Tynan A et al. Survival as a function of HbA(1c) in people with Type 2 diabetes: A retrospective cohort study. Lancet. 2010; 375: 481-9.
22. Hornick T, Aron DC. Managing diabetes in the elderly: Go easy, individualize. Cleve Clin J Med. 2008; 75: 70-8.
23. Joslin Diabetes Center. Guideline for Care of Older Adults with Diabetes. Available from: (accessed 21 February 2011).
24. Pogach L, Engelgau M, Aron D. Measuring progress toward achieving hemoglobin A1c goals in diabetes care: Pass/fail or partial credit. JAMA. 2007; 297: 520-3.
25. Pogach LM, Brietzke SA, Cowan CL Jr et al.; VA/DoD Diabetes Guideline Development Group. Development of evidence-based clinical practice guidelines for diabetes: The Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care. 2004; 27(S2): B82-9.
26. Landman GW, van Hateren KJ, Kleefstra N, Bilo HJ. The relationship between glycaemic control and mortality in patients with Type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract. 2010; 60: 172-5.
27. Stratton IM, Adler AI, Neil HAW et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000; 321: 405-12.
28. Ray KK, Seshasai SRK, Wijesuriya S et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet. 2009; 373: 1765-72.
29. Thompson CJ, Cummings JF, Chalmers J, Gould C, Newton RW. How have patients reacted to the implications of the DCCT? Diabetes Care. 1996; 19: 876-9.
30. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33: 676-82.
31. International Diabetes Federation. Global Guideline on Pregency and Diabetes. Available from: (accessed 21 February 2011).
32. Oglesby AK, Secnik K, Barron J, Al-Zakwani I, Lage MJ. The association between diabetes related medical costs and glycemic control: A retrospective analysis. Cost Eff Resour Alloc. 2006; 4: 1-8.
33. Dowell MA, Rozell B, Roth D, Delugach H, Chaloux P, Dowell J. Economic and clinical disparities in hospitalized patients with Type 2 diabetes. J Nurs Scholarsh. 2004; 36: 66-72.
34. Bloomgarden ZY. A1C: Recommendations, debates, and questions. Diabetes Care. 2009; 32: e141-7.